Arabic malt energy drinks, protein Snickers bars, an edible Barbie dream house, Snoop Dogg chips; if any of those exotic snacks pique your interest there are places to get them in Kelowna. Seoulful Convenience specializes in Korean snacks and drinks, In 'N' Out Arabic Market has Middle Eastern treats to spice things up and 24 Hour Snacks is a shop that carries bizarre delights you won’t find in almost any other brick and mortar shop. Jessie Lal and her husband Dean Ahmad opened 24 Hour Snacks just over a year ago. “Ninety-nine point nine per cent of the people that come in here are in a good mood,” Ahmad said. “So it's been pretty fun getting to meet people and seeing people's reactions and seeing things.” The shop has candy flavoured drinks, chips inspired by fast food places like Pizza Hut and Subway, big spicy pickles, protein Snickers bars and other snacks that would give your tastebuds whiplash. Ahmad also likes seeing people feel nostalgic when they see classic snacks. “It's a lot of retro candies and things you haven't seen in a while. So it's exciting to see people get excited from stuff from their childhood and things like that,” he said. “The best part, I think, is when you have a grandparent come in with their kid, and their grandkid, they'll come in there and see something they've seen in their childhood. We have those Popeye candy sticks, like the cigarette sticks back in the day.” READ MORE: iN PHOTOS: How a Kamloops food photographer makes mouthwatering images Ahmad said the idea came from a relative who sold strange snacks during the pandemic. “My wife's cousin had the idea, he did it during COVID back in Vancouver. And the rare kind of exotic snacks, everything, and it went quite well. And we realized there's nothing like this in Kelowna, so we thought we'd give it a shot. And the reception has been great, people have been really happy with it,” he said. The exotic snack business isn’t easy. Limey The British Shop was a store in Kelowna that sold British snacks, and they announced that they had to close up shop on Nov. 1. The shop said importing their inventory was too expensive. “Market forces have made it impossible to continue. Everyone is struggling right now, and we understand, we really do, but we simply haven’t had the sales that get us through,” Limey said in its closing announcement on social media. “Shipping is through the roof and every which way we turn we are loaded with new and increasing costs that we can’t, and won’t, pass on. On top of all this, we have done nothing but struggle to get stock in, Port Strikes, Rail Strikes, Postal Strikes, it’s all killing small business.” Von Schweets is a novelty candy shop a few doors down from 24HR Snacks, but Ahmad said there isn’t a rivalry. “There's nowhere quite like this. They're a traditional candy store with the bulk candies and things like that. I wouldn't call us competitors. We just kind of complement each other,” Ahmad said. To contact a reporter for this story, email Jesse Tomas or call 250-488-3065 or email the editor . You can also submit photos, videos or news tips to the newsroom and be entered to win a monthly prize draw. Find our Journalism Ethics policy here. We welcome your comments and opinions on our stories but play nice. We won't censor or delete comments unless they contain off-topic statements or links, unnecessary vulgarity, false facts, spam or obviously fake profiles. If you have any concerns about what you see in comments, email the editor in the link above. SUBSCRIBE to our awesome newsletter here .Singapore 2024: A new prime minister in saddle, city-state elevates ties with India
Both Real Madrid and Manchester City could benefit from looking to La Liga for potential signings in the upcoming transfer window. The Spanish top flight is renowned for producing top-quality players who possess the technical skills and tactical acumen to succeed at the highest level. Furthermore, the financial implications of the COVID-19 pandemic have made La Liga clubs more willing to negotiate reasonable transfer fees for their players, presenting an opportunity for Real Madrid and Manchester City to secure value-for-money signings.Title: Premier League Club Sacks Liverpool Referee Abuser, Terminates Contract ImmediatelyDAN HODGES: Tories willingly flung the borders wide open - Daily Mail
The manhunt for the mysterious gunman who killed UnitedHealth CEO Brian Thompson outside of a midtown Manhattan hotel early Wednesday morning rages on — but even days later, the New York Police Department has yet to name a suspect. The NYPD has made a big deal about its investigation so far, which has involved collecting evidence he left at the crime scene and locating surveillance camera footage purportedly showing the killer at an uptown hostel. If it sounds like energy is flagging, fear not: according to FOX Business reporter Charles Gasparino , law enforcement is trying to get the most out of footage with the help of — you guessed it — artificial intelligence, which will allegedly play a "big role in nailing the ID." "His mask, the point out, didn't totally cover his face," an NYPD police source reportedly told Gasparino. "Bone structure was showing through the rest of it, and AI will come up with a pretty clear match they believe." And CNN has also reported that the NYPD is using facial recognition software . ( Futurism has reached out to the NYPD for clarification and additional details.) But whether such an AI will actually help crack the case remains anything but clear. In fact, netizens were quick to point out the technology's many shortcomings, suggesting the police department was lost in the weeds and throwing out buzzwords because its investigation is dead in the water. "Oh so he's GONE gone," one account tweeted in response to Gasparino. "BREAKING: the police are looking for a man with nine fingers on one hand, two legs that merge into one, and a face that constantly shifts every two frames," one Bluesky user joked , referring to the many bizarre outputs of generative AI models . One thing's for sure: the case will be a high-profile test of whether AI can actually help in policing, after numerous high-profile fumbles . According to the Associated Press , the killer pulled down his mask while flirting with an employee at the hostel, giving a less obscured view of his face. The perpetrator used a fake New Jersey ID to check in. Thompson was the CEO of the largest health insurance companies in the world in terms of revenue. His death has sparked a massive debate online as many of those who have been negatively affected by the notoriously greedy and deficient health insurance system have celebrated his passing. Further winding AI into the saga, UnitedHealth has been accused of using an AI algorithm to deny and override claims to elderly patients that had been approved by their doctors. A Senate report earlier this year found that UnitedHealthcare and other insurers' denial rates for prior authorizations had surged in recent years, according to the AP . There's a good chance the killer's attack was motivated by animus toward an industry whose brutal business model has led to the deaths of countless Americans. Case in point, the words "deny," "defend" and "depose" were written on shell casings recovered at the crime scene. More on the incident: Reddit Mods Delete Doctors Slamming Insurance Industry After CEO's Murder Share This ArticleTo address this serious breach of trust and potential health risks to our beloved pets, the authorities made the decision to swiftly seal and secure the implicated pet food products for further examination. Samples were collected from different batches and sent for laboratory testing to verify the accuracy of the ingredients listed on the labels.
One of the most iconic and enduring symbols of the Porsche brand is its logo - a prancing horse rearing up on its hind legs, framed by a sleek, chromed circle. This visual representation captures the spirit of Porsche perfectly - powerful, dynamic, and always pushing the boundaries of what is possible in automotive design and engineering.
One of the film's standout features is its breathtaking cinematography, which captures the beauty of the story's setting in stunning detail. The visuals are complemented by a hauntingly beautiful soundtrack that sets the tone for the film's emotional depth. Viewers can expect to be captivated by the on-screen chemistry between the lead actors, whose performances have already garnered critical acclaim.For Esposito, a move to Inter Milan would represent a significant step up in his career and a chance to showcase his talents on a bigger stage. The opportunity to link up with top-class players and challenge for silverware could be too tempting to turn down for the ambitious forward.
In the midst of this turmoil, the need for urgent and sustained international support cannot be overstated. The international community must come together to provide much-needed aid and assistance to the people of Syria, helping to alleviate their suffering and pave the way for a more stable and prosperous future. Humanitarian efforts must be ramped up, and long-term development initiatives implemented to address the root causes of the crisis.PROVIDENCE, Rhode Island, Nov. 22, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. ( NASDAQ : OCEA), today announced that on November 18, 2024, it received a notice from The Nasdaq Stock Market LLC ("Nasdaq”) stating that because the Company has not yet filed its Quarterly Report on Form 10-Q for the period ended September 30, 2024 (the "Form 10-Q”), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic reports with the Securities and Exchange Commission (the "SEC”). Ocean Biomedical is delayed in filing the Form 10-Q as a result of previously disclosed developments with respect to filing of its 10-K for the year ended December 31, 2023. The current notice will have no immediate effect on the listing or trading of Ocean Biomedical's common stock on Nasdaq, although there can be no assurances that further delays in the filing of the Form 10-Q will not have an impact on the listing or trading of the company's common stock. On October 16, 2024, Staff notified the Company that since it failed to timely file its Form 10-K for the year ended December 31, 2023, and its Forms 10-Q for the periods ended March 31, 2024 and June 30, 2024, the Company's securities were subject to delisting. The Company is now delinquent in the filing its form 10-Q for the period ended September 30, 2024. Accordingly, this matter serves as an additional basis for delisting the Company's securities from The Nasdaq Stock Market. This is formal notification that the Nasdaq Hearings Panel (the "Panel”) will consider this matter in their decision regarding the Company's continued listing on The Nasdaq Capital Market, which hearing is scheduled for December 16, 2024. The Company intends to file the delinquent Forms 10-Q and 10-K as soon as practicable. About Ocean Biomedical Ocean Biomedical, Inc. is a Providence, Rhode Island-based biopharma company with an innovative business model that accelerates the development and commercialization of scientifically compelling assets from research universities and medical centers. Ocean Biomedical deploys the funding and expertise to move new therapeutic candidates efficiently from the laboratory to the clinic to the world. Ocean Biomedical is currently developing five promising discoveries that have the potential to achieve life-changing outcomes in lung cancer, brain cancer, pulmonary fibrosis, and the prevention and treatment of malaria. The Ocean Biomedical team is working on solving some of the world's toughest problems, for the people who need it most. To learn more, visit www.oceanbiomedical.com . Forward-Looking Statements The information included herein and in any oral statements made on behalf of Ocean Biomedical, Inc. (the "Company”) or otherwise in connection herewith include "forward-looking statements” within the meaning of the "safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as "estimate,” "plan,” "project,” "forecast,” "intend,” "will,” "expect,” "anticipate,” "believe,” "seek,” "target,” or other similar expressions that predict or indicate future events or trends or that are not statements of historical matters, although not all forward-looking statements contain such identifying words. These forward-looking statements include, but are not limited to, statements regarding estimates and forecasts of financial and performance metrics and expectations; the expected timing and success of IND filings for our initial product candidates; statements regarding the expected timing of our IND-enabling studies; the frequency and timing of filing additional INDs; expectations regarding the availability and addition of future assets to our pipeline; the advantages of any of our pipeline assets and platforms; the potential benefits of our product candidates; potential commercial opportunities; the timing of key milestones for our programs; the future financial condition, results of operations, business strategy and plans, and objectives of management for future strategy and operations; and statements about industry trends and other companies in the industry. These forward-looking statements are based on various assumptions, whether or not identified herein, and on the current expectations of the Company's management, and they are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on by any investor as, a guarantee, an assurance, a prediction, or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Any discoveries announced by the Company are based solely on laboratory and animal studies. The Company has not conducted any studies that show similar efficacy or safety in humans. There can be no assurances that any treatment tested by the Company will prove safe or effective in humans, and that any clinical benefits of any such treatment is subject to clinical trials and ultimate approval of its use in patients by the FDA. Such approval, if granted, could be years away. Forward-looking statements are predictions, projections, and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. These forward-looking statements are not guarantees of future performance, conditions, or results, and involve a number of known and unknown risks, uncertainties, assumptions, and other important factors, many of which are outside the control of the Company that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. You should carefully consider the foregoing factors and the other risks and uncertainties that are described in the Company's Annual Report on Form 10-K for the year ended December 31, 2023 and other documents filed by the Company from time to time with the SEC and which are and are available at www.sec.gov . These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. We do not undertake any obligation to update any forward-looking statements made by us. These forward-looking statements should not be relied upon as representing the Company's assessments as of any date subsequent to the date of this filing. Accordingly, undue reliance should not be placed upon the forward-looking statements. Contacts: Ocean Biomedical Investor Relations [email protected] Kevin Kertscher Communications Director
As the date of the retrial looms closer, the anticipation and tension in the air are palpable. The public is eager to see how the proceedings will unfold and what new revelations may come to light in the courtroom.Title: Confrontation Erupts as a City Management Officer in Nanning Gets Slapped by Onlooker in Provocative Encounter
The highly anticipated Peaky Blinders film “won’t be the end” of the popular gangster series, creator Steven Knight has said. Oscar-winner Cillian Murphy is reprising his role as Birmingham gangster Tommy Shelby for the film, which is set following the events of the original BBC drama which ran for six series from 2013 to 2022. Following the film wrapping production, Knight has revealed that it will be around a year before the project is released. Speaking to Times Radio about a future release date, Knight said: “It’s a bit too soon for that, but you know, you can sort of work out that it will be about a year.” Asked if there are any more plans for Peaky Blinders beyond the film, he replied: “It’s interesting you should ask that question because the film is coming out and that won’t be the end.” The screenwriter was questioned if that meant fans could expect more series in the future, but he refused to provide more details. The film is believed to be titled The Immortal Man and has been teased to involve new conflicts for the Shelby family set during the Second World War. THAT'S A WRAP. The Peaky Blinders film has completed production. 📸: Robert Viglasky — Netflix (@netflix) Saltburn and The Banshees Of Inisherin star Barry Keoghan will join fellow Irish actor Murphy in the new film. Earlier this month a photo was shared by Netflix of the pair looking jubilant while wearing flat caps and suits as the streamer confirmed filming had wrapped on the project. Other returning cast members include British actors Stephen Graham as union organiser Hayden Stagg and Sophie Rundle as Ada Shelby, while Dune actress Rebecca Ferguson and Pulp Fiction actor Tim Roth have also joined the project. Tom Harper, who previously directed episodes in the first season in 2013, will return to helm the film. Knight previously told Netflix’s Tudum site: “It will be an explosive chapter in the Peaky Blinders story. No holds barred. Full-on Peaky Blinders at war.” When the series came to an end in 2022 after nine years, Tommy appeared to put his criminal past behind him. Across the six series, the show tackled the rise of fascism, Irish republican politics and communist activities throughout the period after the First World War – along with Tommy’s ambitions in politics. Knight later created a stage adaptation of the show for a limited-run production, titled The Redemption Of Thomas Shelby, which featured performances from Rambert’s dancers and a soundtrack from a live on-stage band.
The "Three Ones of Winter" proverb refers to three specific indicators that are believed to forecast the severity of the upcoming winter season. These indicators are the first snowfall, the length of the first snowfall, and the direction of the first snowfall. According to traditional beliefs, these factors can give important clues about what to expect in terms of temperature and weather conditions in the coming months.The long-awaited mystery surrounding the next installment of the critically acclaimed game "The Fading Light" has finally been lifted, as it was confirmed to make its debut at The Game Awards (TGA) this year. Fans all around the world have been eagerly anticipating the announcement of this new release, and their excitement levels have now reached an all-time high.
Barcelona loses at home for the first time this season
The airstrikes, which began in the early hours of the morning, were carried out with surgical precision, effectively neutralizing Syria's entire network of anti-aircraft defenses. Israeli warplanes, supported by drones and advanced missile systems, targeted key military installations across Syria, leaving a trail of devastation in their wake.Clashes erupt outside Georgia parliament between pro-EU protesters, police
Join 'Sleepgate' and let the world of dreams and relaxation embrace you! #SleepgateDreams #CozyNights #SelfCareRevolutionIt is important to remember that everyone has the right to a safe and healthy environment when visiting public facilities like bathhouses. Authorities are working diligently to uncover the cause of the health issues at the bathhouse in Zhengzhou, and individuals must remain vigilant about their rights in such situations. By staying informed, seeking legal advice when necessary, and documenting any relevant information, individuals can protect themselves and hold accountable those responsible for their suffering.